Table of Contents

NEUROPHARMACOLOGY

• You have access

  The “Kynurenate Test,” a Biochemical Assay for Putative Cognition Enhancers

  Anna Pittaluga, Daniella Vaccari and Maurizio Raiteri

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 82-90;
• You have access

  Effects of Noradrenergic Lesions on MPTP/MPP⁺Kinetics and MPTP-Induced Nigrostriatal Dopamine Depletions

  Francesco Fornai, Maria Grazia Alessandrì, Maria Tilde Torracca, Lucia Bassi and Giovanni Umberto Corsini

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 100-107;
• You have access

  The Pharmacological Characterization of a Novel Selective 5-Hydroxytryptamine_1A Receptor Antagonist, NAD-299

  Lars Johansson, Daniel Sohn, Seth-Olof Thorberg, David M. Jackson, Diana Kelder, Lars-Gunnar Larsson, Lucy Rényi, Svante B. Ross, Carin Wallsten, Håkan Eriksson, Ping-Sheng Hu, Eva Jerning, Nina Mohell and Anita Westlind-Danielsson

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 216-225;
• You have access

  Clozapine and Haloperidol Modulate N-Methyl-d-aspartate- and Non-N-Methyl-d-aspartate Receptor-Mediated Neurotransmission in Rat Prefrontal Cortical Neurons In Vitro

  V. L. Arvanov, X. Liang, J. Schwartz, S. Grossman and R. Y. Wang

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 226-234;
• You have access

  ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine]: I. A Potent and Selective Cholinergic Channel Modulator with Neuroprotective Properties

  James P. Sullivan, Diana Donnelly-Roberts, Clark A. Briggs, David J. Anderson, Murali Gopalakrishnan, Iris C. Xue, Marietta Piattoni-Kaplan, Eduardo Molinari, Jeffrey E. Campbell, David G. Mckenna, David E. Gunn, Nan-Horng Lin, Keith B. Ryther, Yun He, Mark W. Holladay, Susan Wonnacott, Michael Williams and Stephen P. Arneric

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 235-246;
• You have access

  ABT-089 [2-Methyl-3-(2-(S)-pyrrolidinylmethoxy)pyridine dihydrochloride]: II. A Novel Cholinergic Channel Modulator with Effects on Cognitive Performance in Rats and Monkeys

  Michael W. Decker, Anthony W. Bannon, Peter Curzon, Karen L. Gunther, Jorge D. Brioni, Mark W. Holladay, Nan-Horng Lin, Yihong Li, Jerome F. Daanen, Jerry J. Buccafusco, Mark A. Prendergast, William J. Jackson and Stephen P. Arneric

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 247-258;
• You have access

  Interaction Between Hyperthermia and Oxygen Radical Formation in the 5-Hydroxytryptaminergic Response to a Single Methamphetamine Administration

  Annette E. Fleckenstein, Diana G. Wilkins, James W. Gibb and Glen R. Hanson

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 281-285;
• You have access

  Prevention of Amyloid-Like Deposition by a Selective Prolyl Endopeptidase Inhibitor, Y-29794, in Senescence-Accelerated Mouse

  Akira Kato, Atsushi Fukunari, Yoko Sakai and Tohru Nakajima

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 328-335;
• You have access

  Pentobarbital Decreases the γ-Aminobutyric Acid_AReceptor Subunit gamma-2 Long/Short mRNA Ratio by a Mechanism Distinct from Receptor Occupation

  R. F. Tyndale, S. V. Bhave, E. Hoffmann, P. L. Hoffman, B. Tabakoff, A. J. Tobin and R. W. Olsen

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 350-357;
• You have access

  Sequestration of γ-Aminobutyric Acid_A Receptors on Clathrin-Coated Vesicles During Chronic Benzodiazepine Administration In Vivo

  Mohammad H. Jalilian Tehrani and Eugene M. Barnes

  Journal of Pharmacology and Experimental Therapeutics October 1997, 283 (1) 384-390;